An Information Secure Attribution Model for Observing Spurious Drugs in Health Care Organization
Kumaraguru P.1, V. Elantamilan D.2
1Dr. Kumaraguru P. V., Associate Professor & Dean, IT Department, MCA, Gurunanak Arts and College, Madras University Velachery, Chennai, (Tamil Nadu) India.
2Dr. Elantamilan D., Assistant professor, Department of MCA, Gurunanak Arts and Science College, Madras University Velachery, Chennai, (Tamil Nadu) India.
Manuscript received on November 21, 2019. | Revised Manuscript received on December 15, 2019. | Manuscript published on December 30, 2019. | PP: 5309-5313 | Volume-9 Issue-2, December, 2019. | Retrieval Number: B2921129219/2019©BEIESP | DOI: 10.35940/ijeat.B2921.129219
Open Access | Ethics and Policies | Cite | Mendeley
© The Authors. Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Abstract: The goal of the paper is to propose an appropriated secure provenance framework to check the dependability of the medications in the midst of misleading and fake medications. There are various Drug and Cosmetic Acts in the nation for the control of illegal medications however over 58% of the medications are not certified which requires a circulated provenance framework with high level of information security. Aside from the client mindfulness and extreme discipline for such unlawful exercises, an on request administration which will help the end client to know the starting point of the medications, the different changes during preparing and the last vendors. The safe provenance model tends to least loss of security of the pharmaceutical assembling organizations to improve the dependability of the item and furthermore the individuals. The model is actualized as a portable sending model with verified provenance against potential assaults in various health care industry particularly initiating spurious drugs with respect to various scenario.
Keywords: Provenance Framework, Drug and Cosmetic.